IRCT20080901001165N51招募中3 期
Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19
Sina Darou Laboratories Company0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age: equal or more than 18 years;
- •The patient have written consciously and freely consent to participate in the study;
- •The patient's clinical symptoms (dry cough, shortness of breath, fever) confirm COVID-19.
- •Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation.
- •Less than 7 days have passed since the onset of symptoms.
排除标准
- •History of allergy to this nasal spray ingredients;
- •Hypersensitivity reaction while taking this nasal spray;
- •The patient is in another clinical trial at the same time;
- •The patient needs to receive medical care from the intensive care unit;
研究者
相似试验
招募中
3 期
Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxisCOVID-19 pneumonia.COVID-19, virus not identifiedU07.2IRCT20130917014693N10Shahid Beheshti University of Medical Sciences100
招募中
1 期
Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in hospitalized patients with COVID-19COVID-19.COVID-19U07.1IRCT20150808023559N20Ardabil University of Medical Sciences100
已完成
3 期
Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19IRCT20200318046812N1Iran University of Medical Sciences324
招募中
3 期
Treatment of Hydroxychloroquine in Type 2 Diabetes Patients Uncontrolled on Metformin MonotherapyCTRI/2021/11/037750Ipca Laboratories Ltd
招募中
4 期
A Clinical Trial to Study the Safety and Efficacy of Hydroxychloroquine in Patients with Type-2 DaibetesCTRI/2016/02/006599Ipca Laboratories Ltd600